- Title
- Docetaxel plus trabectedin appears active in recurrent or persistent ovarian and primary peritoneal cancer after up to three prior regimens: A phase II study of the Gynecologic Oncology Group
- Creators
- Bradley J. Monk (Author) - Creighton UniversityMichael W. Sill (Author)Parviz Hanjani (Author)Robert Edwards (Author)Jacob Rotmensch (Author)Koen De Geest (Author)Albert J. Bonebrake (Author)Joan L. Walker (Author)
- Additional links
- http://dx.doi.org/10.1016/j.ygyno.2010.11.012
- Publication Details
- Gynecologic Oncology, Vol.120(3), pp.459-463
- Number of pages
- 459-463
- Identifiers
- 991005931545002656
- Academic Unit
- School of Medicine; Obstetrics & Gynecology
- Resource Type
- Journal article
Journal article
Docetaxel plus trabectedin appears active in recurrent or persistent ovarian and primary peritoneal cancer after up to three prior regimens: A phase II study of the Gynecologic Oncology Group
Gynecologic Oncology, Vol.120(3), pp.459-463
2011
PMID: 21144560
Metrics
4 Record Views